| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 626673 | Null | 0.0385067071027343 | 0.24480246 |
| NSC 630307 | Null | 0.0385067071027343 | 0.23895862 |
| NSC 631526 | Naphtho[2,3-d]thiazole-4,9-dione, 2-[(4-nitrophenyl) amino]- | 0.0385067071027343 | 0.40104868 |
| NSC 632620 | 9-Methoxy-2-[(benzoyloxy)methyl]-5,11-dimethyl- 6H-pyrido[4,3-b]carbazolium iodide | 0.0385067071027343 | 0.39167209 |
| NSC 633530 | 1H-Pyrido[3,4-b]indol-1-one, 2,3,4,9-tetrahydro-2-[4-(4- phenyl-1-piperazinyl)butyl]-9-methyl- | 0.0385067071027343 | 0.30987983 |
| NSC 637693 | Ethanedioic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d]thiazol-2-yl)hydrazide, monoethyl ester | 0.0385067071027343 | 0.24225908 |
| NSC 641233 | 2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- | 0.0385067071027343 | 0.13241879 |
| NSC 641297 | ANTINEOPLASTIC-641297 | 0.0385067071027343 | 0.31420576 |
| NSC 644644 | Null | 0.0385067071027343 | -0.14206355 |
| NSC 652809 | Null | 0.0385067071027343 | 0.23643215 |